The development of technologies that allow the detection of circulating tumor cells, cell free DNA, or exosomes, combined with the advancements of sequencing technologies and the identification of novel biomarkers now allow more accurate detection and possible insights into the characteristics of malignant tumors than traditional biopsies...

UCSC Genomics Institute’s director David Haussler will chair a session on “Data Solutions in Clinical Genomics” at the upcoming Personalized Medicine World Conference (PMWC) 2016 Silicon Valley, co-hosted with Stanford Health Care and UCSF on January 24-27. Professor Haussler shared some of his thoughts with...

Like a recurring theme, Illumina - when at JPMorgan Healthcare Conference -is contributing to some of the most clearly heard and most impactful announcements in the space. An obligatory new sequencer was released and along with that, the news of the launch of a new...